abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

10 Mar 2014

Author:
Press Trust of India

Supreme Court asks details on deaths from Centre

See all tags

The Supreme Court directed the Centre to provide details on the number of deaths and severe adverse effects caused to people who were subjected to clinical trials...The court passed the order after it found that there were discrepancies in the numbers given by the petitioner NGO and the government...While the NGO claimed that in 2012 and 2013, there were around 4,000 cases of severe adverse effects of drugs trial, including deaths, the government claimed the figure stood at 506, with 89 cases of deaths...The court also said that compensation was granted only to kin of those who died during the trials and asked why it should not be paid to those who were severely effected but alive...The Supreme Court is hearing a PIL filed by Swastha Adhikar Manch seeking directions for regulation of clinical trials of new drugs and chemical entities.

Timeline